Ivan Martin, PhD
University Hospital Basel, University of Basel, Switzerland
Prof. Dr. Ivan Martin studied Biomedical Engineering at the University of Genova where he obtained his PhD in 1996. Between 1996 and 1999 he was a postdoctoral associate at Harvard/MIT. He joined the Department of Biomedicine (DBM) at the University Hospital of Basel in 1999 as leader of the Tissue Engineering Research Group, in close coordination with the surgical units. In 2007 he was appointed Professor for Tissue Engineering at the University of Basel and from 2021 he is Director of the DBM. From 2004 to 2009 he was the first president of the European section of the Tissue Engineering Regenerative Medicine International Society (TERMIS), and later Chair of the TERMIS Strategic Alliance Committee. In 2018 he was elected as member of the Swiss Academy of Medical Sciences. He is currently Chair of the ‘Mesenchymal stromal cell committee’ and member of the ‘Orthopaedics and Musculoskeletal Committee’ of the International Society for Cellular and Gene Therapy (ISCT). He is part of the editorial boards of 6 international journals. His group includes scientists from the biological, engineering and clinical fields, dedicated to develop solid scientific basis for innovative translational strategies in regenerative surgery. In this field he is author of more than 300 peer-reviewed papers on international journals (H-index of 101), inventor on 12 patent applications and recipient of grants from the main funding bodies, including the prestigious European Research Council. The developed science and technology have been translated into different clinical trials for cell-based cartilage and bone repair, and into the founding of a spin-out company for the commercialization of bioreactors for 3D cell culture (Cellec Biotek AG).